143 related articles for article (PubMed ID: 34831905)
21. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
22. Predictors of illness acceptance in women with endometriosis.
Andysz A; Merecz-Kot D
Health Psychol Rep; 2021; 9(3):240-251. PubMed ID: 38084229
[TBL] [Abstract][Full Text] [Related]
23. Normalization of the Mini-MAC (Mental Adjustment to Cancer) Questionnaire among Cancer Patients.
Czerw A; Religioni U; Szymański F; Nieradko-Heluszko A; Mękal D; Hering D; Kowalczuk A; Merks P; Borowska M; Bogdan M; Pajewska M
Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886329
[TBL] [Abstract][Full Text] [Related]
24. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
Schoen RE; Weissfeld JL; Kuller LH
Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
[TBL] [Abstract][Full Text] [Related]
25. Reduced risk of breast, endometrial and ovarian cancer in women with celiac disease.
Ludvigsson JF; West J; Ekbom A; Stephansson O
Int J Cancer; 2012 Aug; 131(3):E244-50. PubMed ID: 21953605
[TBL] [Abstract][Full Text] [Related]
26. Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women's Health Initiative.
Adams SV; Quraishi SM; Shafer MM; Passarelli MN; Freney EP; Chlebowski RT; Luo J; Meliker JR; Mu L; Neuhouser ML; Newcomb PA
Environ Health Perspect; 2014 Jun; 122(6):594-600. PubMed ID: 24633137
[TBL] [Abstract][Full Text] [Related]
27. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Cancers of Female Organs among Patients with Diabetes Type 2 in Kelantan, Malaysia: Observations over an 11 Year Period and Strategies to Reduce the Incidence.
Jalil NA; Zin AA; Othman NH
Asian Pac J Cancer Prev; 2015; 16(16):7267-70. PubMed ID: 26514522
[TBL] [Abstract][Full Text] [Related]
29. Pain Perception and Acceptance of Illness in Patients Undergoing Phacoemulsification Cataract Surgery under Drip Anesthesia.
Kowalczuk K; Cybulski M; Cybulski Ł; Krajewska-Kułak E
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31581551
[TBL] [Abstract][Full Text] [Related]
30. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
31. Acceptance of illness by women with breast cancer.
Cipora E; Konieczny M; Sobieszczański J
Ann Agric Environ Med; 2018 Mar; 25(1):167-171. PubMed ID: 29575856
[TBL] [Abstract][Full Text] [Related]
32. Patient mental adjustment to selected types of cancer.
Religioni U; Czerw A; Deptała A
Psychiatr Pol; 2018 Feb; 52(1):129-141. PubMed ID: 29704420
[TBL] [Abstract][Full Text] [Related]
33. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer.
Tulinius H; Egilsson V; Olafsdóttir GH; Sigvaldason H
BMJ; 1992 Oct; 305(6858):855-7. PubMed ID: 1422397
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer.
Hogervorst JG; Schouten LJ; Konings EJ; Goldbohm RA; van den Brandt PA
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2304-13. PubMed ID: 18006919
[TBL] [Abstract][Full Text] [Related]
35. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
36. A healthy lifestyle index and its association with risk of breast, endometrial, and ovarian cancer among Canadian women.
Arthur R; Kirsh VA; Kreiger N; Rohan T
Cancer Causes Control; 2018 Jun; 29(6):485-493. PubMed ID: 29667103
[TBL] [Abstract][Full Text] [Related]
37. The Mini-Mental Adjustment to Cancer (Mini-MAC) scale: construct validation with a Greek sample of breast cancer patients.
Anagnostopoulos F; Kolokotroni P; Spanea E; Chryssochoou M
Psychooncology; 2006 Jan; 15(1):79-89. PubMed ID: 15880660
[TBL] [Abstract][Full Text] [Related]
38. Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer.
Lambe M; Wigertz A; Garmo H; Walldius G; Jungner I; Hammar N
Cancer Causes Control; 2011 Aug; 22(8):1163-71. PubMed ID: 21688131
[TBL] [Abstract][Full Text] [Related]
39. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
Jareid M; Thalabard JC; Aarflot M; Bøvelstad HM; Lund E; Braaten T
Gynecol Oncol; 2018 Apr; 149(1):127-132. PubMed ID: 29482839
[TBL] [Abstract][Full Text] [Related]
40. Association between quality of life and positive coping strategies in breast cancer patients.
Velasco L; Gutiérrez Hermoso L; Alcocer Castillejos N; Quiroz Friedman P; Peñacoba C; Catalá P; Sánchez-Román S
Women Health; 2020 Oct; 60(9):1063-1069. PubMed ID: 32752953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
